Skip to main content
2022 PRIM&R Annual Conference Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Reg Required
Pre-Reg Required
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
Additional Fee
Additional Fee
CPIA Icon
CPIA Icon
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Deep Dive Series
Deep Dive Series
Networking Series
Networking Series
Workshop Series
Workshop Series
Vendor Insight Series
Vendor Insight Series
Thought Leader Series
Thought Leader Series
Pillars Icon
Pillars Icon
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
New for 2020
New for 2020
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back

2022 PRIM&R Annual Conference

Pharma/Biotech Perspectives

Flexibility and Innovation in Research Oversight Processes

E08 - The Patients are Waiting! Balancing the Pressure of Getting New Therapies to Clinical Trial

Wednesday, December 14, 2022
1:30 PM – 2:30 PM ET
Location: Livestreamed
Livestreaming Session Icon IACUC/Animal Care and Use Deep Dive Series
This session will explore how to balance the pressures of getting new therapies to clinical trial while ensuring robust study design and providing the best animal welfare possible. Examples of the ways IACUCs and scientists/clinician scientists have found to facilitate agile review and study start times while ensuring high quality pre-clinical studies will be discussed.

Learning Objectives:

  • Explore the unique pressures in pre-clinical studies as a critical step before new therapies can progress to clinical trials
  • Discuss case studies that provide examples of what is at risk if pre-clinical studies are rushed or delayed
  • Learn ways to facilitate agile but comprehensive review of pre-clinical studies to support the appropriate transition to clinical trials